We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,617 results
  1. Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications

    The induced pluripotent stem cell (iPSC) technology has transformed in vitro research and holds great promise to advance regenerative medicine. iPSCs...

    Jonas Cerneckis, Hongxia Cai, Yanhong Shi in Signal Transduction and Targeted Therapy
    Article Open access 26 April 2024
  2. A resource of induced pluripotent stem cell (iPSC) lines including clinical, genomic, and cellular data from genetically isolated families with mood and psychotic disorders

    Genome-wide (GWAS) and copy number variant (CNV) association studies have reproducibly identified numerous risk alleles associated with bipolar...

    Sevilla D. Detera-Wadleigh, Layla Kassem, ... Francis J. McMahon in Translational Psychiatry
    Article Open access 16 December 2023
  3. Growth rates of human induced pluripotent stem cells and neural stem cells from attention-deficit hyperactivity disorder patients: a preliminary study

    Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental polygenic disorder that affects more than 5% of children and adolescents...

    Cristine Marie Yde Ohki, Natalie Monet Walter, ... Edna GrĂĽnblatt in Journal of Neural Transmission
    Article Open access 17 February 2023
  4. Phagocytosis model of calcium oxalate monohydrate crystals generated using human induced pluripotent stem cell-derived macrophages

    Macrophages play a role in nephrolithiasis, offering the possibility of develo** macrophage-mediated preventive therapies. To establish a system...

    Tomoki Okada, Atsushi Okada, ... Takahiro Yasui in Urolithiasis
    Article 30 March 2024
  5. Induced Pluripotent Stem Cell–Based Modeling of Single-Ventricle Congenital Heart Diseases

    Purpose of Review

    Congenital heart disease includes a wide variety of structural cardiac defects, the most severe of which are single ventricle...

    Lauren E. Parker, Leonie M. Kurzlechner, Andrew P. Landstrom in Current Cardiology Reports
    Article 17 March 2023
  6. Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells

    Purpose of Review

    The advent of induced pluripotent stem cells (iPSC) has paved the way for new in vitro models of human cardiomyopathy. Herein, we...

    Tarek Khedro, Jason M. Duran, Eric D. Adler in Current Cardiology Reports
    Article 03 June 2022
  7. Modeling tuberous sclerosis complex with human induced pluripotent stem cells

    Background

    Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder with a birth incidence of 1:6000 in the United States that is...

    Weibo Niu, Benjamin Siciliano, Zhexing Wen in World Journal of Pediatrics
    Article 27 June 2022
  8. Opportunities and limitations for studying neuropsychiatric disorders using patient-derived induced pluripotent stem cells

    Neuropsychiatric disorders affect a large proportion of the global population and there is an urgent need to understand the pathogenesis and to...

    Yan Hong, Qian Yang, ... Guo-li Ming in Molecular Psychiatry
    Article 13 February 2023
  9. PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells

    Background

    Base editing via CRISPR-Cas9 has garnered attention as a method for correcting disease-specific mutations without causing double-strand...

    Takafumi Hiramoto, Yuji Kashiwakura, ... Tsukasa Ohmori in Communications Medicine
    Article Open access 19 April 2023
  10. Chenodeoxycholic acid rescues axonal degeneration in induced pluripotent stem cell-derived neurons from spastic paraplegia type 5 and cerebrotendinous xanthomatosis patients

    Background

    Biallelic mutations in CYP27A1 and CYP7B1 , two critical genes regulating cholesterol and bile acid metabolism, cause cerebrotendinous...

    Yongchao Mou, Ghata Nandi, ... Xue-Jun Li in Orphanet Journal of Rare Diseases
    Article Open access 06 April 2023
  11. Generation of human A9 dopaminergic pacemakers from induced pluripotent stem cells

    The degeneration of nigral (A9) dopaminergic (DA) neurons causes motor symptoms in Parkinson’s disease (PD). We use small-molecule compounds to...

    Hong Li, Houbo Jiang, ... Jian Feng in Molecular Psychiatry
    Article 24 May 2022
  12. Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration

    Impaired proteostasis is associated with normal aging and is accelerated in neurodegeneration. This impairment may lead to the accumulation of...

    Sidhartha Mahali, Rita Martinez, ... Celeste M. Karch in Translational Psychiatry
    Article Open access 10 December 2022
  13. Hair-follicle-associated pluripotent (HAP) stem cells differentiate into mature beating cardiomyocyte sheets on flexible substrates in vitro

    Cardiomyocytes have been differentiated from various stem cells such as human embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC),...

    Nanako Takaoka, Michiko Yamane, ... Yasuyuki Amoh in Medical Molecular Morphology
    Article 10 May 2022
  14. Generation of muscle progenitors from human-induced pluripotent stem cells

    Background

    Small molecules have a role in the differentiation of human-induced pluripotent stem cells (hiPSCs) into different cell linages. The aim of...

    Article Open access 04 July 2022
  15. Iris-derived induced pluripotent stem cells that express GFP in all somatic cells of mice and differentiate into functional retinal neurons

    When regenerated tissue is generated from induced pluripotent stem cells (iPSCs), it is necessary to track and identify the transplanted cells....

    Noriko Hiramatsu, Naoki Yamamoto, ... Kazuyoshi Imaizumi in Medical Molecular Morphology
    Article 06 August 2022
  16. Targeting NMDA receptors in neuropsychiatric disorders by drug screening on human neurons derived from pluripotent stem cells

    NMDA receptors (NMDARs), a prominent subtype of glutamatergic receptors, are implicated in the pathogenesis and development of neuropsychiatric...

    Wenbo Zhang, P. Joel Ross, ... Michael W. Salter in Translational Psychiatry
    Article Open access 09 June 2022
  17. PTCH1-null induced pluripotent stem cells exclusively differentiate into immature ectodermal cells with large areas of medulloblastoma-like tissue

    Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder with an increased incidence of tumors, such as basal cell carcinomas...

    Kazuaki Nagao, Chise Kato, ... Toshiyuki Miyashita in Discover Oncology
    Article Open access 27 May 2022
  18. Modeling Cardiac SARS-CoV-2 Infection with Human Pluripotent Stem Cells

    Abstract

    Although SARS-CoV-2, the causative virus of the global COVID-19 pandemic, primarily affects the respiratory tract, it is now recognized to...

    Sarah J. Rockwood, Madelyn Arzt, Arun Sharma in Current Cardiology Reports
    Article 22 October 2022
  19. Comparison of gene expression between human and mouse iPSC-derived cardiomyocytes for stem cell therapies of cardiovascular defects via bioinformatic analysis

    Background

    Preclinical studies have demonstrated the potential use of induced pluripotent stem cells (iPSCs) to treat cardiovascular disease (CVD). In...

    Ryan Bellman, Jishizhan Chen, ... Wenhui Song in Translational Medicine Communications
    Article Open access 17 March 2023
  20. Membrane remodelling triggers maturation of excitation–contraction coupling in 3D-shaped human-induced pluripotent stem cell-derived cardiomyocytes

    The prospective use of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) for cardiac regenerative medicine strongly depends on...

    Fatemeh Kermani, Matias Mosqueira, ... Nina D. Ullrich in Basic Research in Cardiology
    Article Open access 29 March 2023
Did you find what you were looking for? Share feedback.